These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 5572915)

  • 1. [Comparative study of the melphalan and of the cyclophosphamide in the treatment of Kahler's disease].
    Bontoux D; Chenbit D; Delbarre F
    Therapeutique; 1971 Jan; 47(1):27-32. PubMed ID: 5572915
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognosis of Kahler's disease in patients treated and not treated with alkylating agents (apropos of 45 cases)].
    Saporta L; Hugon C; Rondier J; Bontoux D; Delbarre F
    Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):11-8. PubMed ID: 5079686
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of myeloma].
    Le Chevallier PL
    Sem Hop; 1971 Jan; 47(4):249-51. PubMed ID: 4322132
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of Kahler's disease].
    Foa J; Carcassonne Y
    Sem Hop; 1976 Jan; 52(3):165-71. PubMed ID: 186874
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative trial of melphalan and cyclophosphamide in the treatment of Kahler's disease].
    Bontoux D; Chenebit D; Delbarre F
    Rev Rhum Mal Osteoartic; 1970 Dec; 37(12):817-24. PubMed ID: 5500879
    [No Abstract]   [Full Text] [Related]  

  • 6. [Amylosis of the nerve in Kahler's disease].
    Buge A; Escourolle R; Poisson M; Rancurel G; Hauw JJ
    Ann Med Interne (Paris); 1974 Apr; 125(4):359-63. PubMed ID: 4433098
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclophosphamide vs melphalan in treatment of plasma cell myeloma.
    Rivers SL; Patno ME
    JAMA; 1969 Feb; 207(7):1328-34. PubMed ID: 4179565
    [No Abstract]   [Full Text] [Related]  

  • 8. Bence Jones proteins and light chains of immunoglobulins. XV. Effect of corticosteroids on synthesis and excretion of Bence Jones protein.
    Solomon A
    J Clin Invest; 1978 Jan; 61(1):97-108. PubMed ID: 618916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ophthalmoplegia revealing Kahler's disease].
    Ardouin M; Urvoy M; Eon JY; Le Blay R
    Bull Soc Ophtalmol Fr; 1978 Dec; 78(12):897-9. PubMed ID: 755570
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of myelomatosis--M.R.C. trial.
    Galton DA
    Br Med J; 1971 May; 2(5757):323-4. PubMed ID: 4930211
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of plasma cell myeloma with cytotoxic agents.
    Bergsagel DE; Pruzanski W
    Arch Intern Med; 1975 Jan; 135(1):172-6. PubMed ID: 803363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide.
    Bergsagel DE; Cowan DH; Hasselback R
    Can Med Assoc J; 1972 Nov; 107(9):851-5. PubMed ID: 4653931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial Kahler's disease. Immunological and karyotype study of a case].
    Manigand G; Sarrazin A; Demuth L; Schoen E; Deparis M; Ropartz C; Rivat L
    Presse Med (1893); 1970 Sep; 78(40):1741-3. PubMed ID: 5507164
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myeloma : symptoms, diagnosis, treatment].
    Piguet H; Borg JY; Monconduit M; Bizet M
    Rev Prat; 1979 Jan; 29(3):333-6, 339-44, 347-8. PubMed ID: 419356
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute myelogenous leukemia in myelomatosis].
    Tidsskr Nor Laegeforen; 1977 Feb; 97(4):175-7. PubMed ID: 265102
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple myeloma--development of alternative malignancy following successful chemotherapy.
    Holt JM; Robb-Smith AH; Callender ST; Spriggs AI
    Br J Haematol; 1972 May; 22(5):633. PubMed ID: 4503794
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of Kahler's disease with hypoglycemia].
    Tulliez M; Fendler JP; Duprey J; Beuve-Méry P; Fritel D
    Ann Med Interne (Paris); 1971 Apr; 122(4):501-4. PubMed ID: 5556263
    [No Abstract]   [Full Text] [Related]  

  • 18. [Non-secreting myeloma with myelomatous kidney. A case of parciall resistance to melphalen and cyclophosphamide with favorable response to nitrosourea combination].
    Peña Yáñez A; Bermúdez JM; Raya J; Salmerón J; Palomo S
    Rev Clin Esp; 1976 Dec; 143(6):543-50. PubMed ID: 796906
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple myeloma. II. The value of melphalan.
    Bernard DB; Lynch SR; Bothwell TH; Bezwoda WR; Stevens K; Shulman G
    S Afr Med J; 1974 May; 48(24):1026-8. PubMed ID: 4835772
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prognosis of multiple myeloma].
    Morell A; Skvaril F; Rüst HP; Spengler GA; Brunner K; Barandun S
    Schweiz Med Wochenschr; 1970 Nov; 100(46):1990-2. PubMed ID: 5507847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.